GlaxoSmithKline PLC
LSE:GSK

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
LSE:GSK
Watchlist
Price: 1 394 GBX 1.09% Market Closed
Market Cap: 56.9B GBX
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

GSK Price Targets Summary
GlaxoSmithKline PLC

Wall Street analysts forecast GSK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSK is 1 672.53 GBX with a low forecast of 1 201.9 GBX and a high forecast of 2 772 GBX.

GSK Lowest Forecast
Wall Street Target
1 201.9 GBX
14% Downside
GSK Average Forecast
Wall Street Target
1 672.53 GBX
20% Upside
GSK Highest Forecast
Wall Street Target
2 772 GBX
99% Upside
Lowest
Price Target
1 201.9 GBX
14% Downside
Average
Price Target
1 672.53 GBX
20% Upside
Highest
Price Target
2 772 GBX
99% Upside
GlaxoSmithKline PLC Competitors:
Price Targets
IPCALAB
IPCA Laboratories Ltd
19% Upside
LQDA
Liquidia Corp
95% Upside
4536
Santen Pharmaceutical Co Ltd
45% Upside
C
214370
Caregen Co Ltd
53% Upside
IPCALAB
IPCA Laboratories Ltd
19% Upside
LQDA
Liquidia Corp
95% Upside
4536
Santen Pharmaceutical Co Ltd
45% Upside
C
214370
Caregen Co Ltd
53% Upside
SNT
Syntara Ltd
249% Upside
ORMP
Oramed Pharmaceuticals Inc
44% Upside

Revenue
Forecast

Revenue Estimate
GlaxoSmithKline PLC

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 1%. The projected CAGR for the next 3 years is 6%.

1%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
GlaxoSmithKline PLC

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 2%. The projected CAGR for the next 3 years is 11%.

2%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
GlaxoSmithKline PLC

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's net income is 14%. The projected CAGR for the next 3 years is 17%.

14%
Past Growth
17%
Estimated Growth
Estimates Accuracy
45%
Average Beat
What are analyst estimates?

See Also

Summary
GSK intrinsic value, competitors valuation, and company profile.
DCF Valuation
GSK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GSK stock valuation using valuation multiples.
Wall Street Estimates
GSK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GSK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GSK's stock price target?
Price Target
1 672.53 GBX

According to Wall Street analysts, the average 1-year price target for GSK is 1 672.53 GBX with a low forecast of 1 201.9 GBX and a high forecast of 2 772 GBX.

What is GlaxoSmithKline PLC's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 1%. The projected CAGR for the next 3 years is 6%.

What is GlaxoSmithKline PLC's Operating Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 2%. The projected CAGR for the next 3 years is 11%.

What is GlaxoSmithKline PLC's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's net income is 14%. The projected CAGR for the next 3 years is 17%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 248,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.